openPR Logo
Press release

Drug Delivery Devices Market Provides an In-Depth Insight of Sales and Trends, Forecast to 2024 with Prominent Players| Roche, Pfizer,B.Braun, Novartis AG

05-28-2020 07:00 AM CET | Health & Medicine

Press release from: Business Industry Reports

/ PR Agency: Business Industry Reports
Drug Delivery Devices

Drug Delivery Devices

research study covers the current scenario and growth prospects of the Drug Delivery Devices market (2020-2024) according to the analysis . This study includes a extensive analysis of the key segments of the industry and also the regional analysis that are taken place throughout the country.

Global Drug Delivery Devices Market Overview:

A recent report by Business Industry Reports offers an in-depth analysis of global Drug Delivery Devices market from 2020 to 2024. It also edifies various sides such as key drivers, prominent developments, and various market opportunities for businesses to gain maximum profit in the projected period.

Drug delivery devices are focused tools used for the delivery of a drug or beneficial agent complete a exact route of management. The devices are used one or more than one times for medical treatments. Drug delivery devices present exclusive challenges in all factors of product growth from controlling tactic to design and material considerations through planning and executing testing methodologies. Drug delivery is a significant method of organization of pharmaceutical combinations, which achieve therapeutic outcome in humans or animals. A growth in the number of diabetes patients and an upsurge in the occurrence of cancer and respiratory diseases are lashing the use of drug delivery devices among patients and physicians.

The global drug delivery devices market is fuelled by fast development in technology, surge in funding for drug research, changing lifestyles, increase in patient partiality for drug delivery devices, and rise in government support for research & development. Moreover, a rise in the occurrence of diabetes, which leads to hyperglycemia, is anticipated to lash the drug delivery devices market. Moreover, a increase in the number of patients selecting the use of new drug-delivery systems needed to backing patient mobility is projected to enhance the market in the near future. However, high cost of research & development and devices, high maintenance cost, and introduction of substitute therapy in established countries are projected to restrain the drug delivery devices market in the forecasts year.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/260590 .

Numerous drug formulations such as insulin and antibiotics are managed through drug delivery devices. These devices help in growing the efficacy of the drug delivery system by directing time, dosage, and place of release of the drugs in the body. Drug delivery devices may be conventional or implantable. Infusion pumps such as ambulatory infusion pumps, insulin infusion pumps, implantable infusion pumps, enteral pumps, and volumetric infusion pumps are some of the drug delivery devices used to administer drugs in medical systems. Infusion catheters such as valves, IV sets, needles, and cannulas are also used for drug delivery. Transcellular and paracellular routes are the routes commonly used to administer drugs. Hospitals, long-term care services, and home care providers are the main users of drug delivery devices.

Market Key Players

The Drug Delivery Devices market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. Vendors are continually introducing smart medical devices and are investing massively toward the development of next-generation healthcare . Vendors compete based on the quality of Drug Delivery Devices and solutions, services, and advanced characteristics and their performance is affected by factors such as strong competition, accelerated technological advances, and technological obsolescence.

Cipla

Baxter International

Nipro Corporation

Roche

Boehringer Ingelheim...more

Segmentations

The Drug Delivery Devices market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

Product Type Segmentation

Injection type

Mucosal type

Implanted type

Industry Segmentation

Pharmaceutical companies

Hospitals

Clinics

Regional Segmentation

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)


Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Global Drug Delivery Devices Report 2020" @ https://www.businessindustryreports.com/buy-now/260590/single .

Global Industry News:

Roche : Roche's Port Delivery System with ranibizumab shows positive phase III results in neovascular age-related macular degeneration

27 May 2020 - Roche today announced positive topline results from the phase III Archway study, evaluating Port Delivery System with ranibizumab (PDS) in people living with neovascular or "wet" age-related macular degeneration (nAMD). PDS is a permanent refillable eye implant, approximately the size of a grain of rice, which continuously delivers a customised formulation of ranibizumab over a period of months. The Archway trial met its primary endpoint, demonstrating that patients with PDS who received refills every six months achieved visual acuity outcomes equivalent to those receiving monthly ranibizumab 0.5 mg injections. In Archway, PDS was generally well-tolerated with a favorable benefit-risk profile.

Neovascular AMD is a leading cause of blindness in people aged 60 and older globally. The current standard of care for nAMD requires patients to visit their ophthalmologist as often as monthly for eye injections of anti-vascular endothelial growth factor (VEGF) therapy to help maintain vision gains and/or prevent vision loss. This high treatment burden with anti-VEGF therapy can lead to under-treatment of nAMD and, potentially, less than optimal vision outcomes.

"For people around the world receiving frequent eye injections for neovascular AMD, this continuous delivery system could greatly reduce their treatment burden," said Levi Garraway, M.D., Ph.D., Roche's Chief Medical Officer and Head of Global Product Development. "We look forward to presenting detailed Archway results at future medical meetings and discussing these data with regulatory authorities, with the aim of bringing this new treatment option to patients as soon as possible."

In addition to Archway, the Portal study is investigating the long-term safety and tolerability of PDS for the treatment of nAMD. Furthermore, PDS is also being studied in the Pagoda trial for the treatment of diabetic macular edema (DME), a vision-threatening complication of diabetes.

Full results from the Archway study will be presented at an upcoming medical meeting and submitted to health authorities around the world, including the US Food and Drug Administration and European Medicines Agency, for consideration of regulatory approval for the treatment of nAMD.

Key Points Covered :

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry's value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/260590 .



Major Points in Table of Contents:

Section 1 Drug Delivery Devices Product Definition

Section 2 Global Drug Delivery Devices Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Drug Delivery Devices Shipments

2.2 Global Manufacturer Drug Delivery Devices Business Revenue

2.3 Global Drug Delivery Devices Market Overview

Section 3 Manufacturer Drug Delivery Devices Business Introduction

3.1 Cipla Drug Delivery Devices Business Introduction

3.1.1 Cipla Drug Delivery Devices Shipments, Price, Revenue and Gross profit 2014-2019

3.1.2 Cipla Drug Delivery Devices Business Distribution by Region

3.1.3 Cipla Interview Record

3.1.4 Cipla Drug Delivery Devices Business Profile

3.1.5 Cipla Drug Delivery Devices Product Specification

3.2 Baxter International Drug Delivery Devices Business Introduction

3.2.1 Baxter International Drug Delivery Devices Shipments, Price, Revenue and Gross profit 2014-2019

3.2.2 Baxter International Drug Delivery Devices Business Distribution by Region

3.2.3 Interview Record

3.2.4 Baxter International Drug Delivery Devices Business Overview

3.2.5 Baxter International Drug Delivery Devices Product Specification

3.3 Nipro Corporation Drug Delivery Devices Business Introduction

3.3.1 Nipro Corporation Drug Delivery Devices Shipments, Price, Revenue and Gross profit 2014-2019

3.3.2 Nipro Corporation Drug Delivery Devices Business Distribution by Region

3.3.3 Interview Record

3.3.4 Nipro Corporation Drug Delivery Devices Business Overview

3.3.5 Nipro Corporation Drug Delivery Devices Product Specification ................... Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Delivery Devices Market Provides an In-Depth Insight of Sales and Trends, Forecast to 2024 with Prominent Players| Roche, Pfizer,B.Braun, Novartis AG here

News-ID: 2060149 • Views: 293

More Releases from Business Industry Reports

Cold and Flu Drugs Market Will Hit Big Revenues In Future | Biggest Opportunity …
The Cold and Flu Drugs market 2020 report analyses global acceptance of trends, future growth potential, key drivers, limitations, opportunities, and best practices that are taken place in market. The report also examines growth potential, market sizes and revenue forecasts (2020-2025)across different regions as well as industry verticals. Global Cold and Flu Drugs Market Overview: This Cold and Flu Drugs market study offers a comprehensive analysis of the business models, key strategies,
Tripropargylamine Market Widely Growing Worldwide by Forecast 2020-2025 | Top Ve …
Global Tripropargylamine Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players in the market. This research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. Global Tripropargylamine Market overview: Tripropargylamine is widely used in the synthesis of Cu(I) stabilizing ligands such as tris(3-hydroxypropyltriazolylmethyl)amine (THPTA) and tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) for the copper-catalyzed alkyne-azide cycloaddition
Reinsurance Market Will Be Massively Influenced By Macroeconomic Factors 2020-20 …
The demand for Reinsurance Market 2020 is anticipated to be high for the next few years. By considering this demand we provide latest Reinsurance Market Report which gives complete industry analysis, market outlook, size, growth and forecast till 2025. This report will assist in analyzing the current and future business trends, sales and revenue forecasts. Global Reinsurance Market Overview: The Global Reinsurance Market has also suffered a certain impact, but still maintained
Innovative Report on CBD Hemp Oil Market with New Business Developments and Top …
Global CBD Hemp Oil Market Synopsis: The exclusive research report on the Global CBD Hemp Oil Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global CBD Hemp Oil Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. The Global CBD Hemp Oil Market has also suffered

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning